Member Info for Jungmana

Riskassessor make sure you get some of this on Tuesday as is Heading for 2p+ next week This is a gem on the market

Yes he bought lots of bloe about 4p. Done very well there

There were a few 1m buys yesterday. Near 10% of total shares in issue was traded. The placing was just 14m (5% of total ) So I expect this to climb back up tuesday/ Wednesday. Maximum of 2 weeks for delivery of the equipment bought and I learnt will take max 2 days to fix and a day or 2 for tests. So drilling could be on within 3 weeks.

Got some yesterday just under 3p. Yes the CEO 's record has not been good enough and there has been lots of delays. But at £7.5m market cap this is a buy. 31m oil reserve , 250bopd production and the significant drilling to commence late May. This is the time to be buying here imo and I believe should start to climb back up next week. 25m traded yesterday with some chunky buys. Target of 6p before the drill actually starts in 3/4 weeks time. On success we may see double that. I will be adding on Tuesday.

Yes the 60 week market cap high of £12m would equate to about 1.5p share price today. And that's a realistic target short term. So personally I have 1.5p as my target in coming few weeks.

In last 14 months gone from 15p down to 0.44p today. Shares in issue from about 80m to 790m today. You do the maths. So imho this is cheap today and has an exciting future with The new focus as iconic labs. The big drag over last few months was the ehgosf funding and that looks like is at an end.

The market cap this time last year was about £12m ( about 80m shares then and 15p share price) . the company only had the widecell business which comprises of 3 sectors. Today the market cap is £3.5m about ( 800m shares at 0.44p). So judge for yourselves. Is the market cap that is important NOT the number of shares in issue.

That's a big buy there. Bodes well for tomorrow

The placing was just 120m shares (about 7% dilution) so not much. Imo looking at the volumes since the placing, this should be free to move by end of the coming week. Won't be surprised to see 3p+ by Friday.

Looks like all today's trades are buys . This should 2 to 3 times today's market cap for fair valuations based on the business and contracts imo. Onwards and upwards

We could see 0.2p+ this week. Too undervalued right now.

This is capitalised at 3.7p with the deal rns a few weeks back. See the Align note. Once the dotted lines are all signed expect closer to 10p. Cheap at 1.8p and a bounce to 2p+ coming. Anyone buying now is paying less than Align, the directors and others who participated in the recent placing

http://www.alignresearch.co.uk/pathfinder-minerals/pathfinder-minerals-game-changing-news-8-long-yrs-mozambique-licence-return-now-sight/

The Align notes makes very good reading. This is an attractive investment

Ref Pathfinder Minerals #PFP and news per here - <a href='Http://www.alignresearch.co.uk/pathfinder-minerals/pathfinder-minerals-game-changing-news-8-long-yrs-mozambique-licence-return-now-sight/' target='window'>Http://www.alignresearch.co.uk/pathfinder-minerals/pathfinder-minerals-game-changing-news-8-long-yrs-mozambique-licence-return-now-sight/</a> … We plan to carry out an interview with CEO in days ahead to provide a little more color. Tweet us your Q's <a href='https://twitter.com/AlignResearch' target='window'>https://twitter.com/AlignResearch</a>

this is what attracted me to take a punt; Updated Scoping Study The Board commissioned an independent technical consultant, 2M Mineral Services Limited, to prepare a revised Scoping Study on the Licence (the "2019 Report"), which includes a revision of the capital and operating costs and pricing assumptions that were presented in the URS/Scott Wilson 2011 scoping study report (the "2011 Report"). This revision has resulted in an estimated pre-tax net present value ("NPV") at a 10 per cent discount rate of US$1.05 billion; with projected annual revenues of US$323 million over a mine life of 30 years. The project internal rate of return ("IRR") is expected to be approximately 25 per cent. The revised findings represent a near doubling of the previously reported equivalent NPV and an increase of 6.1 per cent in the project IRR. A summary of the key differences in scoping study outcomes between the 2011 Report and the 2019 Report is set out below.

With all the £1.14m of contract revenue rolling in this year ( financial year end June 2019) I don't see the need for a placing as some fear. See the details in the recent 850k contract won. Too cheap at 600k market cap right now.

Good results there. Huge cash pile and this lixus licence is definitely the company maker. Very impressive acquisition. Onwards and upwards

I agree there. Short term target of 8 to 10p

As Malcy said they have pulled rabbit out of a hat. Currently sitting just 10% above cash level with the new licences alone valued at conservative 20p. Extremely undervalued imo